https://www.selleckchem.com/pr....oducts/tat-beclin-1-
To evaluate changes in self-reported depression after treatment of fecal incontinence (FI) with sacral neuromodulation. This is a subanalysis of data collected from March 2016 to October 2017 for an Institutional Review Board-approved retrospective cohort study. Demographic information, medical history, psychiatric comorbidities, and the Patient-Reported Outcomes Measurement Information System item bank t-scores were extracted from the electronic medical record. The differences in t-scores were compared with a two-sided p
Like
Comment
Share
